Renal artery stenting slows the rate of renal function decline

Journal of Vascular Surgery

Volumn 45, Issue 4, 2007, Pages 726-732

  Arthurs, Zachary ^a   Starnes, Benjamin ^a   Cuadrado, Daniel ^a   Sohn, Vance ^a   Cushner, Howard ^a   Andersen, Charles ^a  

^a MADIGAN ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

AGED; ARTICLE; BLOOD PRESSURE; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DETERIORATION; FOLLOW UP; HUMAN; HYPERTENSION; KIDNEY ARTERY STENOSIS; KIDNEY FUNCTION; PRIORITY JOURNAL; RENAL ARTERY STENT; RETROSPECTIVE STUDY; SALVAGE THERAPY; STENT;

AGED; ANGIOPLASTY; ANTIHYPERTENSIVE AGENTS; ATHEROSCLEROSIS; BLOOD PRESSURE; COHORT STUDIES; CREATININE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION, RENOVASCULAR; KAPLAN-MEIERS ESTIMATE; KIDNEY; KIDNEY FUNCTION TESTS; ODDS RATIO; PATIENT SELECTION; PROPORTIONAL HAZARDS MODELS; RENAL ARTERY; RENAL ARTERY OBSTRUCTION; RETROSPECTIVE STUDIES; RISK ASSESSMENT; STENTS; TIME FACTORS; TREATMENT OUTCOME; VASCULAR PATENCY;

EID: 33947598896     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2006.12.026     Document Type: Article

References (23)

1. Hunt J.C., and Strong C.G. Renovascular hypertension. Mechanisms, natural history and treatment. Am J Cardiol 32 (1973) 562-574
2. Goldblatt H. Experimental renal hypertension; mechanism of production and maintenance. Circulation 17 (1958) 642-647
3. Tobian L. Relationship of juxtaglomerular apparatus to renin and angiotensin. Circulation 25 (1962) 189-192
4. Webster J., Marshall F., Abdalla M., Dominiczak A., Edwards R., Isles C.G., et al., Scottish and Newcastle Renal Artery Stenosis Collaborative Group. Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. J Hum Hypertens 12 (1998) 329-335
5. Plouin P.F., Chatellier G., Darne B., Raynaud A., and Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group. Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis: a randomized trial. Hypertension 31 (1998) 823-829
6. Rundback J.H., Sacks D., Kent K.C., Cooper C., Jones D., Murphy T., et al. Guidelines for the reporting of renal artery revascularization in clinical trials. J Vasc Interv Radiol 14 (2003) S477-S492
7. Watson P.S., Hadjipetrou P., Cox S.V., Piemonte T.C., and Eisenhauer A.C. Effect of renal artery stenting on renal function and size in patients with atherosclerotic renovascular disease. Circulation 102 (2000) 1671-1677
8. Mitch W.E., Walser M., Buffington G.A., and Lemann Jr. J. A simple method of estimating progression of chronic renal failure. Lancet 2 (1976) 1326-1328
9. Strandness Jr. D.E. Natural history of renal artery stenosis. Am J Kidney Dis 24 (1994) 630-635
10. Zierler R.E., Bergelin R.O., Isaacson J.A., and Strandness Jr. D.E. Natural history of atherosclerotic renal artery stenosis: a prospective study with duplex ultrasonography. J Vasc Surg 19 (1994) 250-257 discussion 257-8
11. van Ampting J.M., Penne E.L., Beek F.J., Koomans H.A., Boer W.H., and Beutler J.J. Prevalence of atherosclerotic renal artery stenosis in patients starting dialysis. Nephrol Dial Transplant 18 (2003) 1147-1151
12. Rimmer J.M., and Gennari F.J. Atherosclerotic renovascular disease and progressive renal failure. Ann Intern Med 118 (1993) 712-719
13. Harden P.N., MacLeod M.J., Rodger R.S., Baxter G.M., Connell J.M., Dominiczak A.F., et al. Effect of renal-artery stenting on progression of renovascular renal failure. Lancet 349 (1997) 1133-1136
14. Radermacher J., Chavan A., Bleck J., Vitzthum A., Stoess B., Gebel M.J., et al. Use of Doppler ultrasonography to predict the outcome of therapy for renal-artery stenosis. N Engl J Med 344 (2001) 410-417
15. Rocha-Singh K.J., Ahuja R.K., Sung C.H., and Rutherford J. Long-term renal function preservation after renal artery stenting in patients with progressive ischemic nephropathy. Catheter Cardiovasc Interv 57 (2002) 135-141
16. Blum U., Krumme B., Flugel P., Gabelmann A., Lehnert T., Buitrago-Tellez C., et al. Treatment of ostial renal-artery stenoses with vascular endoprostheses after unsuccessful balloon angioplasty. N Engl J Med 336 (1997) 459-465
17. Lederman R.J., Mendelsohn F.O., Santos R., Phillips H.R., Stack R.S., and Crowley J.J. Primary renal artery stenting: characteristics and outcomes after 363 procedures. Am Heart J 142 (2001) 314-323
18. Henry M., Amor M., Henry I., Ethevenot G., Tzvetanov K., Courvoisier A., et al. Stents in the treatment of renal artery stenosis: long-term follow-up. J Endovasc Surg 6 (1999) 42-51
19. Fiala L.A., Jackson M.R., Gillespie D.L., O'Donnell S.D., Lukens M., and Gorman P. Primary stenting of atherosclerotic renal artery ostial stenosis. Ann Vasc Surg 12 (1998) 128-133
20. Dorros G., Jaff M., Mathiak L., Dorros II, Lowe A., Murphy K., et al. Four-year follow-up of Palmaz-Schatz stent revascularization as treatment for atherosclerotic renal artery stenosis. Circulation 98 (1998) 642-647
21. Sivamurthy N., Surowiec S.M., Culakova E., Rhodes J.M., Lee D., Sternbach Y., et al. Divergent outcomes after percutaneous therapy for symptomatic renal artery stenosis. J Vasc Surg 39 (2004) 565-574
22. Yutan E., Glickerman D.J., Caps M.T., Hatsukami T., Harley J.D., Kohler T.R., et al. Percutaneous transluminal revascularization for renal artery stenosis: Veterans Affairs Puget Sound Health Care System experience. J Vasc Surg 34 (2001) 685-693
23. Bakker J., Goffette P.P., Henry M., Mali W.P., Melki J.P., Moss J.G., et al. The Erasme study: a multicenter study on the safety and technical results of the Palmaz stent used for the treatment of atherosclerotic ostial renal artery stenosis. Cardiovasc Intervent Radiol 22 (1999) 468-474